E.E. Geduld’s Pacific Biosciences PACB Stock Holding History

E.E. Geduld’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-10,000	Closed	-$90K	–	201
2016 Q3	$90K	Buy	+10,000	New	+$83.6K	0.09%	131
2016 Q2	–	Sell	-10,000	Closed	-$85K	–	180
2016 Q1	$85K	Buy	+10,000	New	+$98.3K	0.12%	106

Other funds holding PACB

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

E.E. Geduld's PACB Position: Q4 2016 in Review

E.E. Geduld increased its Pacific Biosciences (PACB) stake by 143% in Q4 2016, buying an estimated $363K and bringing the position to 85,000 shares worth $323K. The position accounts for 0.18% of the portfolio, ranked #47.

E.E. Geduld first reported a position in PACB in Q4 2015 and has held it in 5 quarters since. The position peaked at $853K in Q4 2015. 115 funds tracked by Wall St. Rank hold PACB as of Q4 2016.

E.E. Geduld held 85,000 shares of Pacific Biosciences worth $323K as of Q4 2016.
E.E. Geduld bought 50,000 Pacific Biosciences shares in Q4 2016, an estimated $363K.
Pacific Biosciences made up 0.18% of E.E. Geduld's portfolio in Q4 2016, its #47 holding.
E.E. Geduld first reported a position in Pacific Biosciences in Q4 2015 and has held it in 5 quarters since.
E.E. Geduld's Pacific Biosciences position peaked at $853K in Q4 2015.
115 funds tracked by Wall St. Rank held Pacific Biosciences as of Q4 2016.

Based on E.E. Geduld's 13F filing for Q4 2016, filed 8 Feb 2017.